par Wolking, Stefan;Moreau, Claudia;McCormack, Mark;Krause, Roland;Krenn, Martin;EpiPGx Consortium, Samuel F;Berkovic, Gianpiero L;Cavalleri, Norman;Delanty, Chantal;Depondt, Michael R ;Johnson, B.P.C.;Koeleman, Wolfgang Gerhard;Kunz, Holger;Lerche, Anthony Guy;Marson, Terence;O'Brien, Slave;Petrovski, Josemir W;Sander, Graeme;Sills, Pasquale;Striano, Federico;Zara, Fritz;Zimprich, Sanjay M;Sisodiya, S;Girard, Patrick;Cossette,
Référence Annals of clinical and translational neurology, 8, 7, page (1376-1387)
Publication Publié, 2021-07-01
Référence Annals of clinical and translational neurology, 8, 7, page (1376-1387)
Publication Publié, 2021-07-01
Article révisé par les pairs
Résumé : | Resistance to antiseizure medications (ASMs) is one of the major concerns in the treatment of epilepsy. Despite the increasing number of ASMs available, the proportion of individuals with drug-resistant epilepsy remains unchanged. In this study, we aimed to investigate the role of rare genetic variants in ASM resistance. |